Offering Nonclinical and Clinical Trial Support

Our nationally recognized team provides expertise in services spanning from basic research to advanced studies under FDA GLP regulations.

science-solutions-hero-img

Expertise

We have commercial, government, and industry partnership opportunities. Our work includes licensing patents, co-investing in furthering intellectual property,

oncology

Oncology

high-throughput-screening

HIGH THROUGHPUT SCREENING

medicinal

MEDICINAL, ANALYTICAL AND COMPUTATIONAL CHEMISTRY

Infectious-Disease-Research

Infectious Disease Research

neuroscience

NEUROSCIENCE

Research Services

We have commercial, government, and industry partnership opportunities. Our work includes licensing patents, co-investing in furthering intellectual property,

bioanalytical-sciences

BIOANALYTICAL SCIENCES

bacteriology-1

BACTERIOLOGY

cell-biology-immunology

CELL BIOLOGY & IMMUNOLOGY

infectious-disease-research-black-corder

INFECTIOUS DISEASE RESEARCH

pharmacokinetic

PHARMACOKINETIC

toxicology

TOXICOLOGY

Meet the Experts

Abi Kulshreshtha, Ph.D.

Chief of Staff

Rebecca Boohaker, PH.D

Associate Fellow of Oncology

Paige Vinson, PH.D.

Director of High Throughput Screening

Monica Mason

Director of Core Services

Alyssa McQuilling, PH.D.

Energy Storage Project Lead

Science Solutions News

Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

March 25, 2021 | Southern Research

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission   TNX-1800 is Based on a Proprietary Vaccine Platform Designed to Stimulate Long ...
Read More
Southern Research and Tonix Pharmaceuticals COVID-19 Vaccine Research Update

Southern Research and Tonix Pharmaceuticals COVID-19 Vaccine Research Update

November 25, 2020 | Southern Research

On the 16th of November, 2020, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced preliminary results for a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 (CoV-2) spike protein after vaccination. The research is part of a...
Read More
Southern Research, Tonix expand COVID-19 vaccine collaboration

Southern Research, Tonix expand COVID-19 vaccine collaboration

July 22, 2020 | Southern Research

Southern Research announced an expansion of its strategic collaboration with New York-based Tonix Pharmaceuticals Holding Corp. to include a study of immune responses to SARS-CoV-2, the virus that causes COVID-19. This research...
Read More